Febuxostat in the therapy of gout: from theory to practice
Gout is a chronic disease that requires permanent urate-lowering therapy. Allopurinol is the gold standard of this therapy. The novel drug febuxostat, a selective xanthine oxidase inhibitor, has been synthesized and introduced into clinical practice in the last 10 years. The paper reviews the litera...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Russo |
| Argitaratua: |
IMA-PRESS LLC
2018-01-01
|
| Saila: | Современная ревматология |
| Gaiak: | |
| Sarrera elektronikoa: | https://mrj.ima-press.net/mrj/article/view/800 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|